[Huntington's disease].

CONCLUSION: No disease-modifying therapy is currently available for HD; however, gene silencing, e.g. through RNA interference, is a promising technique which could lead to effective therapies in due course.
PMID: 25940443 [PubMed - as supplied by publisher]

Source: Der Nervenarzt - May 6, 2015 Category: Neurology Authors: Rollnik JD Tags: Nervenarzt Source Type: research